JP2010526819A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010526819A5 JP2010526819A5 JP2010507607A JP2010507607A JP2010526819A5 JP 2010526819 A5 JP2010526819 A5 JP 2010526819A5 JP 2010507607 A JP2010507607 A JP 2010507607A JP 2010507607 A JP2010507607 A JP 2010507607A JP 2010526819 A5 JP2010526819 A5 JP 2010526819A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- methyl
- group
- hydrogen
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CC(C=C(*)C=C1)C=C1c1nccnc1N1CCN(Cc2c(*)[n](*)nc2*)CC1 Chemical compound CC(C=C(*)C=C1)C=C1c1nccnc1N1CCN(Cc2c(*)[n](*)nc2*)CC1 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91743107P | 2007-05-11 | 2007-05-11 | |
| US60/917,431 | 2007-05-11 | ||
| US97420907P | 2007-09-21 | 2007-09-21 | |
| US60/974,209 | 2007-09-21 | ||
| PCT/US2008/062834 WO2008141020A1 (en) | 2007-05-11 | 2008-05-07 | 2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines and pyridines and 3-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-2-phenyl pyridines as 5-ht7 receptor antagonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010526819A JP2010526819A (ja) | 2010-08-05 |
| JP2010526819A5 true JP2010526819A5 (enExample) | 2011-05-26 |
| JP5210375B2 JP5210375B2 (ja) | 2013-06-12 |
Family
ID=39629131
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010507607A Expired - Fee Related JP5210375B2 (ja) | 2007-05-11 | 2008-05-07 | ５−ｈｔ７受容体拮抗薬としての２−［４−（ピラゾール−４−イルアルキル）ピペラジン−１−イル］−３−フェニルピラジンおよびピリジンならびに３−［４−（ピラゾール−４−イルアルキル）ピペラジン−１−イル］−２−フェニルピリジン |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US8202873B2 (enExample) |
| EP (1) | EP2155717B1 (enExample) |
| JP (1) | JP5210375B2 (enExample) |
| KR (1) | KR101119294B1 (enExample) |
| CN (1) | CN101861312B (enExample) |
| AU (1) | AU2008251584B2 (enExample) |
| BR (1) | BRPI0811446A2 (enExample) |
| CA (1) | CA2684563C (enExample) |
| CY (1) | CY1113457T1 (enExample) |
| DK (1) | DK2155717T3 (enExample) |
| EA (1) | EA016529B1 (enExample) |
| ES (1) | ES2395872T3 (enExample) |
| HR (1) | HRP20120919T1 (enExample) |
| MX (1) | MX2009012126A (enExample) |
| PL (1) | PL2155717T3 (enExample) |
| PT (1) | PT2155717E (enExample) |
| WO (1) | WO2008141020A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2226320A4 (en) * | 2007-12-26 | 2012-07-11 | Eisai R&D Man Co Ltd | PROCESS FOR THE PRODUCTION OF A HETEROCYCLE-SUBSTITUTED PYRIDINE DERIVATIVE |
| MX2012001067A (es) * | 2009-07-31 | 2012-03-16 | Syngenta Participations Ag | Procesos para la alquilacion de pirazoles. |
| WO2011062194A1 (ja) | 2009-11-18 | 2011-05-26 | 武田薬品工業株式会社 | アミノピリジン誘導体 |
| WO2011140333A1 (en) | 2010-05-07 | 2011-11-10 | The Board Of Trustees Of The Leland Stanford Junior University | Identification of stabilizers of multimeric proteins |
| JP5869570B2 (ja) * | 2010-08-10 | 2016-02-24 | シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト | ３−ハロアルキルピラゾールの調製方法 |
| CN105829287B (zh) | 2013-12-20 | 2019-08-27 | 埃斯蒂文制药股份有限公司 | 具有抗疼痛的多重模式活性的哌嗪衍生物 |
| US20160045609A1 (en) | 2014-08-14 | 2016-02-18 | Mamoun M. Alhamadsheh | Conjugation of pharmaceutically active agents with transthyretin ligands through adjustable linkers to increase serum half-life |
| CN104592199A (zh) * | 2015-01-22 | 2015-05-06 | 杭州利巴医药科技有限公司 | 一种取代的1-(2-吡啶基)-吡唑-4-基乙酸及其衍生物和制备方法 |
| CN104945325B (zh) * | 2015-06-19 | 2017-04-05 | 浙江永太科技股份有限公司 | 一种吡唑甲酸衍生物的制备方法 |
| CN116730920A (zh) | 2017-02-17 | 2023-09-12 | 文涵治疗有限公司 | Ag-10的制备方法、其中间体及其盐 |
| MA52137A (fr) | 2018-03-23 | 2021-01-27 | Eidos Therapeutics Inc | Méthodes de traitement de l'amylose ttr à l'aide d'ag10 |
| AU2019321583C1 (en) | 2018-08-17 | 2025-11-27 | Eidos Therapeutics, Inc. | Formulations of AG10 |
| KR102514860B1 (ko) * | 2020-12-01 | 2023-03-29 | 한국과학기술연구원 | 5-ht7 세로토닌 수용체 활성 저해용 바이페닐 피롤리딘 및 바이페닐 다이하이드로이미다졸 유도체 및 이를 유효성분으로 포함하는 약학 조성물 |
| US20240210412A1 (en) * | 2021-04-13 | 2024-06-27 | University Of Virginia Patent Foundation | Sulfonyl-triazole compounds useful as ligands and inhibitors of prostaglandin reductase 2 |
| CN115974785A (zh) * | 2022-12-09 | 2023-04-18 | 南京先进生物材料与过程装备研究院有限公司 | 一种3,5-二取代吡唑类化合物的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2079323B1 (es) * | 1994-06-21 | 1996-10-16 | Vita Invest Sa | Derivados de indol utiles para el tratamiento de la migraña, composicion y uso correspondientes. |
| EP1676844A1 (en) * | 2004-12-28 | 2006-07-05 | Laboratorios Del Dr. Esteve, S.A. | 5-HT7 receptor antagonists |
| WO2004067703A2 (en) | 2003-01-31 | 2004-08-12 | Pfizer Products Inc. | 5ht7 antagonists and inverse agonists |
| US20050080076A1 (en) * | 2003-10-08 | 2005-04-14 | Xanodyne Pharmacal, Inc. | N-desmethyl levomepromazine |
-
2008
- 2008-05-07 DK DK08747748.5T patent/DK2155717T3/da active
- 2008-05-07 BR BRPI0811446-3A2A patent/BRPI0811446A2/pt not_active Application Discontinuation
- 2008-05-07 WO PCT/US2008/062834 patent/WO2008141020A1/en not_active Ceased
- 2008-05-07 US US12/597,255 patent/US8202873B2/en not_active Expired - Fee Related
- 2008-05-07 PL PL08747748T patent/PL2155717T3/pl unknown
- 2008-05-07 CA CA2684563A patent/CA2684563C/en not_active Expired - Fee Related
- 2008-05-07 KR KR1020097022901A patent/KR101119294B1/ko not_active Expired - Fee Related
- 2008-05-07 PT PT87477485T patent/PT2155717E/pt unknown
- 2008-05-07 MX MX2009012126A patent/MX2009012126A/es active IP Right Grant
- 2008-05-07 EA EA200971052A patent/EA016529B1/ru not_active IP Right Cessation
- 2008-05-07 JP JP2010507607A patent/JP5210375B2/ja not_active Expired - Fee Related
- 2008-05-07 AU AU2008251584A patent/AU2008251584B2/en not_active Ceased
- 2008-05-07 EP EP08747748A patent/EP2155717B1/en not_active Not-in-force
- 2008-05-07 CN CN200880015741.XA patent/CN101861312B/zh not_active Expired - Fee Related
- 2008-05-07 HR HRP20120919AT patent/HRP20120919T1/hr unknown
- 2008-05-07 ES ES08747748T patent/ES2395872T3/es active Active
-
2012
- 2012-12-13 CY CY20121101219T patent/CY1113457T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021534124A5 (enExample) | ||
| RU2485131C2 (ru) | Производные пиридина, замещенные гетероциклическим кольцом и фосфоноксиметильной группой и содержащие их противогрибковые средства | |
| JP2014530900A5 (enExample) | ||
| CA2534672A1 (en) | Cyclic amine bace-1 inhibitors having a heterocyclic substituent | |
| HRP20120919T1 (hr) | 2-[4-(pirazol-4-ilalkil)piperazin-1-il]-3-fenilpirazini i -piridini i 3-[4-(pirazol-4-ilalkil)piperazin-1-il]-2-fenilpiridini kao antagonisti receptora 5-ht7 | |
| JP2006524660A5 (enExample) | ||
| JP2005509024A5 (enExample) | ||
| IL205501A (en) | Preparation of preparations for the treatment of arthritis | |
| JP2019510787A5 (enExample) | ||
| RU2017127135A (ru) | Терапевтическое средство против рака желчных протоков | |
| JP2013544276A5 (enExample) | ||
| CA2718383A1 (en) | Heteroaryl-substituted dicyanopyridines and use thereof for treatment of cardiovascular diseases | |
| RU2009117705A (ru) | Производные 2-аминокарбонилпиридина | |
| JP2014037426A5 (enExample) | ||
| JP2007519754A5 (enExample) | ||
| NO341617B1 (no) | Dihydropyrazolpyrimidinonderivater, deres anvendelse i terapi og til behandling av kreft, deres anvendelse for fremstilling av et medikament, og for anvendelse som strålingssensibilisator, farmasøytisk sammensetning derav, samt et kombinert preparat for administrering ved behandling av kreft. | |
| NO20084845L (no) | 2-pyrazinonderivater for behandling av sykdom eller tilstander der inhibiering av neutrofil elastaseaktivitetet er gunstig | |
| JP2017533968A5 (enExample) | ||
| JP2013532652A5 (enExample) | ||
| RU2017116196A (ru) | 2-амино-6-(дифторметил)-5,5-дифтор-6-фенил-3,4,5,6-тетрагидропиридины как ингибиторы васе1 | |
| JP2008508214A (ja) | 女性の性障害の治療用ピペラジン誘導体 | |
| JP2020521767A5 (enExample) | ||
| JP2012530765A5 (enExample) | ||
| CN110225781A (zh) | 噻唑衍生物及其应用 | |
| JP2018513190A5 (enExample) |